BioMall
BGC0222
GENERAL CATALOGUE

BGC0222

HY-P10783 · 50 mg

MedChemExpress · Cat: HY-P10783

Reach 3+ verified distributors

Manufacturer product page

medchemexpress.com/bgc0222.html
Catalog No: HY-P10783
Category: Antibody-drug Conjugate ADC Related
Pack Size: 50 mg
Brand: MedChemExpress

Description

BGC0222 is a novel prodrug of Irinotecan HY-16562 . BGC0222, as a PEG-cRGD-conjugated Irinotecan HY-16562 derivative, could slowly and steadily release Irinotecan HY-16562 . BGC0222 binds to ?V?3 with IC50 values of 4.25 ?M ?V?3 and 58.7 ?M ?V?5 . BGC0222 possesses the property of inducing neovascularization. BGC0222 exhibits good antiproliferation activity in many tumors.

More from MedChemExpress

Rha-PEG3-SMCC
Rha-PEG3-SMCC
HY-142740
Antibody-drug Conjugate ADC Related
PPC-NB
PPC-NB
HY-126530
Antibody-drug Conjugate ADC Related
Taltobulin intermediate-8
Taltobulin intermediate-8
HY-41070
Antibody-drug Conjugate ADC Related
m-PEG8-NHS ester
m-PEG8-NHS ester
HY-W019793
Antibody-drug Conjugate ADC Related
Mal-amido-PEG5-C2-NHS ester
Mal-amido-PEG5-C2-NHS ester
HY-126508
Antibody-drug Conjugate ADC Related
Tisotumab vedotin
Tisotumab vedotin
HY-152963
Antibody-drug Conjugate ADC Related
Muscotoxin A
Muscotoxin A
HY-131058
Antibody-drug Conjugate ADC Related
Methylcyclopropene-PEG4-NHS
Methylcyclopropene-PEG4-NHS
HY-136048
Antibody-drug Conjugate ADC Related